Regression of Vasoproliferative Tumor With Systemic Infliximab
Japiassu RM et al. - The patient underwent treatment with infliximab intravenously for his systemic condition. Regression of the vasoproliferative tumors in both eyes and improvement of macular edema in the left eye was observed. Although the data are limited, anti-TNF antibodies such as infliximab may be useful in the treatment of retinal vascular tumors. [more...]
|
|
|
